Home › Cardiogenic Shock › NCT03378739
Inova Cardiogenic Shock Registry (INOVA SHOCK)
Implementation of a Cardiogenic Shock Team and Clinical Outcomes (INOVA-SHOCK Registry)
Who can join
Ages 18 to 85 · All sexes
Full eligibility criteria
Inclusion Criteria: -Patients at the IHVI with documented Cardiogenic Shock team intervention for acute decompensated heart failure cardiogenic shock, or acute myocardial infarction cardiogenic shock. Exclusion Criteria: -Patients under the age of 18 will be excluded.
About the study
To collect retrospective clinical outcomes related to acute decompensated heart failure cardiogenic shock, acute myocardial infarction cardiogenic shock and compare current versus historical survival rates.
To collect Inova Heart and Vascular Institute (IHVI) site specific outcomes before and after initiation of the Cardiogenic Shock team on January 1, 2017.
To collect outcomes related to implementation of mechanical circulatory support versus no circulatory intervention and type of intervention (extracorporeal membrane oxygenation (ECMO) versus intracorporeal axial-flow (Impella).
• Assess survival at three time points.
What is being tested
- Cardiogenic Shock team activation (procedure)
Sponsor: Inova Health Care Services · Participants: 3,000 · Started: Jan 1, 2018
Contact the study team
- Bhruga Shah · Phone: 703-776-2828
Official record on ClinicalTrials.gov — NCT03378739
Locations in the U.S.
| Virginia | Inova Fairfax Hospital, Falls Church |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.